Literature DB >> 21350826

[Current clinical practise of cardiac resynchronisation therapy in Austria--national results from the European CRT Survey].

Wolfgang Dichtl1, Bernhard Strohmer, Friedrich Fruhwald.   

Abstract

Cardiac resynchronization therapy (CRT) has become an established treatment modality in patients with chronic heart failure, reducing both mortality and morbidity. However, patient selection, implantation and follow-up require great clinical experience. Between 2008 and 2010, the European Society of Cardiology initiated the European CRT survey to describe the current practice and routines associated with CRT implantations in 13 countries. Data from 156 patients collected in 10 Austrian centres were analysed compared to the total 2438 patients enrolled. The survey data showed that general practice did not adhere to the present guidelines. More than one third (36%) of the patients had atrial fibrillation and more than one-fourth (29%) had had a device implanted previously. Altogether, 22% of the patients were in NYHA functional class I or II, and 18% had a LVEF > 35%. Approximately one-fourth of the patients were treated with CRT-P devices (Austria 23%, total 27%). In Austria a higher percentage of patients with non-ischemic cardiomyopathy was selected for CRT than in the other European countries (56% versus 40%, p < 0.0001). Less than a quarter of all patients were females. Different from the rest of Europe, only a minority of CRT implantations were performed by cardiologists in Austria (29% as compared to 89% throughout Europe; p < 0.0001).

Entities:  

Mesh:

Year:  2011        PMID: 21350826     DOI: 10.1007/s00508-011-1542-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  22 in total

1.  2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Authors:  Kenneth Dickstein; Panos E Vardas; Angelo Auricchio; Jean-Claude Daubert; Cecilia Linde; John McMurray; Piotr Ponikowski; Silvia Giuliana Priori; Richard Sutton; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

2.  Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Authors:  Anthony S L Tang; George A Wells; Mario Talajic; Malcolm O Arnold; Robert Sheldon; Stuart Connolly; Stefan H Hohnloser; Graham Nichol; David H Birnie; John L Sapp; Raymond Yee; Jeffrey S Healey; Jean L Rouleau
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

3.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

Review 4.  European cardiac resynchronization therapy survey: rationale and design.

Authors: 
Journal:  Eur J Heart Fail       Date:  2009-03       Impact factor: 15.534

Review 5.  Cardiac resynchronization therapy in patients with a narrow QRS.

Authors:  Johannes Holzmeister; David Hürlimann; Jan Steffel; Frank Ruschitzka
Journal:  Curr Heart Fail Rep       Date:  2009-03

6.  Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome.

Authors:  Christopher Adlbrecht; Martin Hülsmann; Marianne Gwechenberger; Senta Graf; Franz Wiesbauer; Guido Strunk; Cesar Khazen; Isabella Brodnjak; Stephanie Neuhold; Thomas Binder; Gerald Maurer; Richard Pacher
Journal:  Eur J Clin Invest       Date:  2010-06-07       Impact factor: 4.686

7.  Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT.

Authors:  R J van Bommel; J Gorcsan; E S Chung; W T Abraham; F T Gjestvang; C Leclercq; M J Monaghan; P Nihoyannopoulos; C Peraldo; C-M Yu; M Demas; B Gerritse; J J Bax
Journal:  Heart       Date:  2010-07       Impact factor: 5.994

8.  Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy.

Authors:  Eugene S Chung; Rodolphe P Katra; Stefano Ghio; Jeroen Bax; Bart Gerritse; Kathryn Hilpisch; Brett J Peterson; David S Feldman; William T Abraham
Journal:  Eur J Heart Fail       Date:  2010-02-11       Impact factor: 15.534

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction.

Authors:  Erwan Donal; Lars H Lund; Cecilia Linde; Magnus Edner; Stéphane Lafitte; Hans Persson; Fabrice Bauer; John Ohrvik; Pierre-Vladimir Ennezat; Camilla Hage; Ida Löfman; Yves Juilliere; Damien Logeart; Geneviève Derumeaux; Pascal Gueret; Jean-Claude Daubert
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

View more
  1 in total

1.  Clinical outcome after 1 year of cardiac resynchronisation therapy: national results from the European CRT survey.

Authors:  Wolfgang Dichtl; Bernhard Strohmer; Friedrich Fruhwald
Journal:  Wien Klin Wochenschr       Date:  2013-10-22       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.